Pregnancy and cancer: A challenge for obstetrician and oncologist!As the age of child birth is delayed we may be seeing more cases with cancer in pregnancy.At present estimated incidence of cancer in pregnancy is estimated to be around 1 in 1000

Bevacizumab is the first antiangiogenic therapy to be approved in advanced adenocarcinoma lung in combination with chemotherapy. Dose used in different trial was different and varied from 7.5 mg/kg 3 weekly to 15 mg/kg every 3 weeks. Chemotherapy par

Targeted therapy with gefitinib or erlotinib for 2 years is better than chemotherapy as adjuvant in resected non small cell lung cancer stage l to llla with EGFR mutation. The result suggest better disease free survival, however overall survival data

Few important clinical pearls in Stage III NSCLC!Stage III NSCLC is a heterogeneous disease and carefully selected patients have better survival when surgery is integrated as a part of multimodality treatment approach.MRI brain with contrast shou

DIET IN PATIENTS ON CHEMOTHERAPY:Patient suffering from cancer suffer from change or loss of taste, decreased appetite. These symptoms are aggravated by presence of vomiting, constipation and diarrhea. The factors leading to these are multifactorial

Now long term survival is possible in some stage IV solid cancers with the use of targeted, hormonal, chemotherapy drugs. The list includes:1) Stage IV hormone receptor positive metastatic breast cancer.2) Stage IV her2 nu positive metastatic breas

Cancer treatment is complex and requires a team of cancer specialist. It is important to keep in mind that cancer is not a single disease and there are about 200 different types of cancer, to add to the complexity each is staged differently and subse

IMMUNOTHERAPY IN LUNG CANCER- THE FUTURE OF CANCER CARE.Any cancer and lung cancer in particular creates a highly immunosuppressive environment locally i.e. our bodies immune cells are unable to recognize cancer cells.This is made possible by exp